Early side effects include nausea, vomiting, constipation, and abdominal discomfort, typically appearing during dose escalation weeks and diminishing within days to weeks
This approach can reduce peak drug levels and may improve tolerability
Mechanism of action
ESM Tables 13
Thnh phn: 4g EAA 4g BCAA t l 2:1:1 (2000 mg L-Leucine, 1000 mg L-Isoleucine , 1000 mg L-Valine) 1640 mg L-Lysine HCl 890 mg L-Threoline 660 mg L-Phenylalanin 580 mg L-Methionine 140 mg L-Histidine 90 mg L-Tryptophan 1000 mg Citrulline malate 666 mg L - citrulline 1000 mg L-Glutamine 375 mg Magnesium u im ni bt: - Sn phm cha ti 8g EAA trong c 4g BCAA, mt hm lng cao trong mi khu phn gip h tr xy dng v bo v c bp
As such, our work demonstrates that the oxidative stress biomarkers during Long COVID are quite similar to those found during the acute phase, except for AOPP, nitrotyrosine and TAC levels, which were altered in acute COVID-19 but not in Long COVID